Skip to main content

Effects of Ergot DH-Alkaloids on the Metabolism and Function of the Brain. An Approach Based on Studies with DH-Ergonine

  • Chapter
  • 51 Accesses

Abstract

The effects of ergot alkaloids on the central nervous system are well known. Bradycardia, vomiting, and vasomotor and pressoreceptor inhibition are responses controlled from the medulla oblongata. Hypothalamic and diencephalic effects of ergot alkaloids have been observed chiefly with lysergic acid derivatives of small molecular size. In 1968 investigations carried out with the hypothermic isolated perfused cat head showed that Hydergine had a stimulatory effect on disturbed cerebral activity [1, 2, 3, 4]. Similar effects of Hydergine on the central nervous system have been confirmed in clinical studies recently [5, 6].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Emmenegger, H., Meier-Ruge, W.: Pharmacology 1, 65 (1968).

    Article  PubMed  CAS  Google Scholar 

  2. Emmenegger, H.: VI Internat. Congr. of Neuropathol., p. 1179. Paris: Masson & Cie 1970.

    Google Scholar 

  3. Meier-Ruge, W.: In: “Zerebrale arterielle Durchblutungsstorung”, Ed. H. Hess, p. 146. Stuttgart/New York: Schattauer-Verlag 1970.

    Google Scholar 

  4. Meier-Ruge, W.: Triangel 8, 334 (1968).

    Google Scholar 

  5. Roubicek, J. et al: J. Amer. Geriat. Soc. 20, 222 (1972).

    PubMed  CAS  Google Scholar 

  6. Herzfeld, U. et al: Arztl. Forsch. 26, 215 (1972).

    PubMed  CAS  Google Scholar 

  7. Maur et al: Canad. J. biochem. Physiol. 40, 1427 (1962).

    Article  PubMed  CAS  Google Scholar 

  8. Joanny, P. et al: Com. Rend. Soc. Biol. 160, 1295 (1966).

    CAS  Google Scholar 

  9. Geiger, A. et al: Amer. J. Physiol. 177, 138 (1954).

    PubMed  CAS  Google Scholar 

  10. Geiger, A.: Physiol. Rev. 38, 1 (1958).

    PubMed  CAS  Google Scholar 

  11. Emmenegger, H. et al.: Helv. physiol. pharmacol. Acta 21, 239 (1963).

    Google Scholar 

  12. Norris, W., Pappius, H. M.: Arch. Neurol. 23, 248 (1970).

    PubMed  CAS  Google Scholar 

  13. Streichenberg, G. et al.: Thérapie 25, 1003 (1970).

    Google Scholar 

  14. Hossmann, K.: Experimental Neurol. 32, 163 (1971).

    Article  CAS  Google Scholar 

  15. Quadbeck, G.: Verh. dtsch. Ges. Path. 56, 106 (1972).

    CAS  Google Scholar 

  16. Armitage, A. K. et al: Brit. J. Pharmacol. 35, 152 (1969).

    CAS  Google Scholar 

  17. Bhattacharya, J. C. et al: Res. Comm. Chem. Pathol. Pharmacol. 1, 99, 109 (1970).

    CAS  Google Scholar 

  18. Itil, T. M.: Adv. Neuropsychopharmacol., Edit. O. Vinar, Votava & Bradley, p. 199. Amsterdam: North-Holland Publ. 1971.

    Google Scholar 

  19. Itil, T. M. et al: In: “Drugs, Development and Brain Function”, Ed. W. L. Smith, C. Th. Chapter 9, p. 145. Springfield 1971.

    Google Scholar 

  20. Dolce, G, Decker, H.: Res. Comm. Chem. Pathol. Pharmacol 3, 523 (2972).

    Google Scholar 

  21. Iwangoff, P., Enz, A.: Agents and Actions (Basel) 2, 223 (1972).

    Article  PubMed  CAS  Google Scholar 

  22. Iwangoff, P., Enz, A.: Experientia 29, 1067 (1973).

    Article  PubMed  CAS  Google Scholar 

  23. Murad, F. et al: J. biol. Chem. 237, 1233 (1962).

    PubMed  CAS  Google Scholar 

  24. Butcher, R. W., Sutherland, E. W.: J. biol. Chem. 237, 1244 (1962).

    PubMed  CAS  Google Scholar 

  25. Erwin, V. G: Molec. Pharmacol. 5, 615 (1969).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Cerletti, A., Emmenegger, H., Enz, A., Iwangoff, P., Meier-Ruge, W., Musil, J. (1974). Effects of Ergot DH-Alkaloids on the Metabolism and Function of the Brain. An Approach Based on Studies with DH-Ergonine. In: Genazzani, E., Herken, H. (eds) Central Nervous System. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65714-6_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-65714-6_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-65716-0

  • Online ISBN: 978-3-642-65714-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics